Tirzepatide — lab test, June 2026
COA 2606180160 matches Kovera Labs's public record. So this test doesn't rest on our review alone — the lab confirms it too.
Asce2606180160Test results
This is a purity and identity analysis. Sterility, endotoxins, and heavy metals were not screened — a high purity figure says nothing about those.
About this test
Label 30 mg · Lab measured 30.11 mg
100% of label, basis not stated — shown as printed. Reconstituted with 2 mL, a 50-unit draw holds 7.5 mg on both the label figure and the measured one.
One vial from this lot was weighed by the laboratory, not yours. This page reports what the certificate says; it does not recommend a dose.
| Report number | 2606180160 |
|---|---|
| Portal lookup | ✓ Lab-verified |
| Checked | 15 Jul 2026date taken from the record, not from a logged check |
| Checked by | Peptigrity staff, against the lab's portal |
| PDF vs portal | Kovera Labs's portal shows validity only |
| Weight | Counts as one lab test |
Independent HPLC purity analysis of Tirzepatide, performed by Kovera Labs on June 21, 2026. Reported purity: 99.83%. Net content: 30.11 mg against 30 mg labeled (100% of label). Endotoxins: Pass, Assay Sensitivity: ≤0.05 EU/mL. Batch White Cap. Sample source: shop-provided. Certificate of analysis attached.
Certificate of analysis
Have you tested this peptide?
Submit your third-party lab test to help the community verify purity claims. Every report is reviewed before publication.
Community discussion